Solez K, Ideura T, Silvia C B, Hamilton B, Saito H
Kidney Int. 1980 Sep;18(3):309-22. doi: 10.1038/ki.1980.141.
Clonidine, an antihypertensive drug that inhibits renin release and causes a water diuresis in normal animals, was tested for its ability to reduce the severity of post-ischemic acute renal failure produced in rabbits by clamping the left renal pedicle for 1 hour and removing the opposite kidney. Clonidine significantly lessened renal failure when given during, or 1 hours after, the ischemic insult in dehydrated rabbits. It was also effective when given during the ischemic insult in vasopressin-treated water-drinking rabbits but not in control water-drinking rabbits. In vasopressin-treated rabbits, clonidine lessened renal failure observed 2 days after the ischemic insult despite the fact that in the immediate postischemic period it lowered total renal blood flow, produced hypotension, and did not bring about lower plasma renin levels. Clonidine treatment resulted in less outer medullary microvascular damage (demonstrated by colloidal carbon staining), higher outer medullary blood flow 1 to 2 hours after unclamping, fewer casts, and higher creatinine clearance and free water clearance/creatinine clearance 4 to 6 hours after unclamping compared with controls. The effect of clonidine was unrelated to plasma renin activity. Clonidine did not alter plasma vasopressin concentration. Demeclocycline and lithium, two agents that blunt renal responsiveness to vasopressin, had a beneficial effect in dehydrated animals similar to that of clonidine, but the angiotensin II antagonist saralasin and the angiotensin converting enzyme inhibitor SQ20881 did not. Normal rabbits given a large dose of vasopressin in oil plus clonidine had significantly greater urine output and free water clearance and lower urine osmolality than did rabbits given vasopressin in oil alone. These results suggest that clonidine may be beneficial because it prevents ischemic microvascular injury in the renal outer medulla, an effect that may decrease tubular obstruction by lessening desquamation of damaged tubular cells or cell constituents into the tubular lumen. Clonidine may also decrease formation of obstructive hyaline casts in collecting ducts by blunting the kidney's response to vasopressin and increasing tubular fluid flow rate.
可乐定是一种降压药,可抑制肾素释放并使正常动物产生水利尿。本研究检测了可乐定减轻家兔肾缺血性急性肾衰竭严重程度的能力,具体方法是钳夹家兔左肾蒂1小时并切除对侧肾脏。在脱水家兔的缺血损伤期间或损伤后1小时给予可乐定,可显著减轻肾衰竭。在给予血管升压素的饮水家兔缺血损伤期间给予可乐定也有效,但在对照饮水家兔中无效。在给予血管升压素的家兔中,尽管在缺血后即刻可乐定降低了肾总血流量、导致了低血压且未使血浆肾素水平降低,但它仍减轻了缺血损伤2天后观察到的肾衰竭。与对照组相比,可乐定治疗导致外髓微血管损伤减轻(通过胶体碳染色显示)、松开肾蒂后1至2小时外髓血流量增加、管型减少、松开肾蒂后4至6小时肌酐清除率和自由水清除率/肌酐清除率升高。可乐定的作用与血浆肾素活性无关。可乐定未改变血浆血管升压素浓度。去甲金霉素和锂这两种减弱肾脏对血管升压素反应的药物,在脱水动物中具有与可乐定类似的有益作用,但血管紧张素II拮抗剂沙拉新和血管紧张素转换酶抑制剂SQ20881则没有。给予油剂中加有大剂量血管升压素的正常家兔可乐定后,其尿量和自由水清除率显著高于仅给予油剂中血管升压素的家兔,尿渗透压则更低。这些结果表明,可乐定可能有益,因为它可预防肾外髓的缺血性微血管损伤,这种作用可能通过减少受损肾小管细胞或细胞成分脱入肾小管腔来减少肾小管阻塞。可乐定还可能通过减弱肾脏对血管升压素的反应并增加肾小管液流速来减少集合管中阻塞性透明管型的形成。